Recommendation ID
What non-pharmacological interventions are effective in reducing spasticity in people with Multiple Sclerosis (MS)?
Any explanatory notes
(if applicable)
Spasticity is a common symptom affecting up to 80% of people with MS. Many people with MS also experience spasms, which are sudden, involuntary, often painful movements affecting any part of the body. Spasticity can range from a feeling of tightness or stiffness in a limb, especially the legs, which cause mild problems with walking, to a tightening of the muscles throughout the body which is so severe that the person is unable to move voluntarily and is confined to a wheelchair or bed. If left unmanaged in the severe stage, it can lead to the secondary complications of muscle shortening, permanent contractures and pain. Although medications exist which reduce spasticity, many people with MS cannot tolerate the side effects, especially of tiredness, which can compound their fatigue. This means that other, non-pharmacological interventions need to be identified which can reduce spasticity and improve function and independence in people with MS.

Source guidance details

Comes from guidance
Multiple sclerosis in adults: management
Date issued
October 2014

Other details

Is this a recommendation for the use of a technology only in the context of research? No  
Is it a recommendation that suggests collection of data or the establishment of a register?   No  
Last Reviewed 27/11/2014